CD-Venture
Investment Details
Investor Type
Venture Capital
Asset Class Focus
Venture Capital
Stage Focus
Early Stage, Series A, Series B, Growth, Late Stage, Pre-IPO
Geographical Focus
United States, United Kingdom, Canada, Germany, Hong Kong, Japan, Australia, Singapore, France, Denmark, Switzerland, Luxembourg, South Korea, Austria, Netherlands, New Zealand, Sweden, Belgium, Norway, Finland
Industries Focus
- Healthcare
- Digital Health
- Pharmaceuticals
- Medical Devices
- Diagnostics
- Medtech
- Biotechnology
- Life Science
- Regenerative Medicine
- Oncology
- Neurology
- Cardiology
- Infectious Diseases
- Therapeutics
- Immunology
- Rare Diseases
- Biopharmaceuticals
- Health IT
- Biomaterials
- Orphan Drugs
Investment Size:
5,000,000 to 20,000,000 USD
Investor Details Founded: 2003
CD-Venture is a venture capital firm based in Heidelberg, Germany, specializing in early-stage investments within the life science sector. The firm focuses on companies with high growth potential in areas such as biotechnology, pharmaceuticals, and medical devices. CD-Venture aims to support innovative businesses that are developing groundbreaking solutions in healthcare and life sciences.
The firm's investment strategy encompasses various stages, including early-stage, Series A, Series B, growth, late-stage, and pre-IPO investments. CD-Venture has a diverse geographical focus, with investments in countries such as the United States, Germany, the United Kingdom, France, Switzerland, the Netherlands, Sweden, Denmark, Norway, Finland, Austria, Belgium, Luxembourg, Canada, Australia, New Zealand, Singapore, Hong Kong, Japan, and South Korea. This broad reach allows the firm to tap into a wide array of innovative companies across different markets.
CD-Venture's portfolio includes investments in companies like Panaya, a provider of software solutions for enterprise resource planning systems, and Phenex Pharmaceuticals, a biopharmaceutical company specializing in nuclear hormone receptors. The firm's commitment to the life science sector is evident through its strategic investments aimed at advancing healthcare solutions globally.
Requirements
- High growth potential
- Innovative solutions in healthcare and life sciences
- Early-stage companies
Contact
[Official Website Hidden]
[HQ Location Hidden]
[Email Hidden]
[Contact Number Hidden]
Portfolio Companies
- Panaya
- Phenex Pharmaceuticals
Mentioned In
-
$49.95
-
$39.95
-
$19.95
-
$24.95
-
$99.00
-
$245.00
Claim this Investor
Are you an official representative of CD-Venture?
Claim this investor to update information, manage your profile, and get a verified seal.
Claim